GEROVITAL H3 (GH3) Tablets and Injections Dr Ana Aslan - Anti Aging Therapy
GEROVITAL H3 Source:
http://www.gerovitalcosmetic.com /
http://www.gerovital-h3.com
Gerovital H3 treatment has a long and glorious history since it was invented by Prof. Dr. Ana Aslan in the 1950s. Celebrities from the past, but also from the present, some even crossing our threshold, have benefited from the antiaging effects of procaine, the basic substance in the preparation patented by Ana Aslan.
Many people want to know the Gerovital H3 injectable treatment regimen, but because there are also some side effects and contraindications to the treatment, geriatric specialists, the only ones who can recommend this treatment on prescription, prefer to determine whether the person who wants to do this therapy is eligible during a consultation. If we are talking about a female person, she must also undergo a gynecological consultation prior to the therapy. On the other hand, the Gerovital ampoule treatment, being strictly injectable, cannot be administered to people who are taking anticoagulant treatment or have coagulation diseases.
What is the Gerovital H3 treatment?
Gerovital H3 treatment is a eutrophic, anti-aging or anti-aging treatment (more recently, slowaging) applied for almost 70 years, performed in the form of Gerovital H3 injectable or Gerovital H3 pills (or dragees), or combined only by geriatric and gerontological specialists.
H2: For what conditions is Gerovital injectable treatment good?
For detailed indications regarding which conditions it treats, you can search on the internet Gerovital injectable leaflet. In short, Gerovital has effects in degenerative joint pathologies (intraarticular injections), neurological (benefits in neurodegenerative diseases), lowers blood cholesterol levels and regenerates body tissues (visible in the skin). Due to its chemical structure, procaine is a monoamine oxidase inhibitor and thus also has an antidepressant effect.
Gerovital injectable and pill leaflet.
5ml ampoules, dragees
Composition: Active substance: procaine hydrochloride + excipients
General warnings:
Use this medical leaflet to supplement the leaflet authorized by the National Medicines Agency.
Gerovital H3 is presented in the form of ampoules (100 mg procaine hydrochloride) or dragees (pills), being a eutrophic medicine that is administered only on the recommendation of a geriatric specialist.
Its role has been demonstrated in degenerative diseases since 1955 in the scientific work Novocaine – eutrophic and rejuvenating factor in the prophylactic and curative treatment of old age written by Acad. C.I. Parhon and Ana Aslan at the RPR Academy Publishing House (facsimile).
Do not use this medicine if any allergic reaction to procaine or to the excipients that make up its composition is detected! Requires allergy tests performed by specialized personnel in geriatric clinics!
Do not administer in injectable form to patients receiving anticoagulant medication or with known coagulation diseases.
Do not use the following classes of drugs simultaneously with gerovital preparations (ampoules and/or dragees): antidiabetic drugs of the sulfonamide type and acetylcholinesterase drugs such as physostigmine.
Do not use this drug during pregnancy and breastfeeding.
Do not use if you have a malignant or potentially malignant tumor, nor in cases of epilepsy.
The preparation contains potassium bisulfite which can trigger bronchospasm and hypersensitivity reactions.
Known therapeutic actions (extracted from the book Let's live long and well - author Adrian Stănescu, Editura Paralela 45, 2018):
direct regenerative effects at the cellular level, including neuronal; acts in degenerative processes of age, chronic degenerative rheumatism, dementia syndromes, etc.
statin-like effect, acts in systemic atherosclerosis;
antioxidant effect (reduces the level of free radicals in the body's cells);
MAO inhibitory effect – antidepressant, but also antiparkinsonian role.
How to administer
The injectable treatment is performed strictly intramuscularly, daily, 5 ml ampoules, 10 days, only on the recommendation of a geriatric specialist, maximum 6 months/year;
Oral treatment with pills is also performed only on the recommendation of a geriatric specialist, daily 12 or 21 days/month, interspersed with or independent of the injectable treatment;
Adverse reactions
allergic reactions as described above;
dizziness, hypotension (rarely hypertensive attack), usually at the beginning of the injectable treatment, therefore requiring specialized monitoring;
state of weakness, fainting – the patient will remain horizontal for 20-30 minutes after the injection.
Gerovital H3 contraindications, possible side effects and things to avoid
As a eutrophic treatment, Gerovital injectable is contraindicated in patients who have or have had a malignant disease (cancer), regardless of location and extent. Rarely does the treatment cause hypotension or/and dizziness, so the person undergoing therapy must stay in bed for 10-15 minutes after the Gerovital injection. Very rarely, an allergic reaction can occur, so the injections (at least the first series) must be performed in a specialized office/clinic.
Anyone aged 40 and over can benefit from the treatment, without imposing a maximum age limit. The treatment consists of intramuscular injections, with prior allergy testing. The duration and treatment schedule are established by the specialist.